Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Greg J. Cairncross"'
Autor:
Richard Marcellus, Osamu Muto, Donna L. Senger, Rima Al-awar, Constanza Rioseco, Ahmed Aman, David L. Kaplan, Michael D. Blough, Marco A. Marra, Lauren Podmore, Greg J. Cairncross, Xueqing Lun, Steven J.M. Jones, David Uehling, Natalie Grinshtein, Stephen M. Robbins, Yaoqing Shen, Jake Lever
Publikováno v:
Oncotarget
Glioblastoma (GBM) is the most lethal and aggressive adult brain tumor, requiring the development of efficacious therapeutics. Towards this goal, we screened five genetically distinct patient-derived brain-tumor initiating cell lines (BTIC) with a un
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3be14bdf7d9517ee953d8fec1df6663
https://eprints.gla.ac.uk/242669/1/242669.pdf
https://eprints.gla.ac.uk/242669/1/242669.pdf
Autor:
Marco A. Marra, Donna L. Senger, Rima Al-awar, Natalie Grinshtein, Mike Moran, Artee Luchman, David Uehling, Constanza Rioseco, Michael Prakesch, Ahmed Aman, Greg J. Cairncross, Steve Robbins, Alessandro Datti, David R. Kaplan, Samuel Weiss, Jeff Wrana, Yaoqing Shen, Steve J.M. Jones
Publikováno v:
Neuro-Oncology. 16:iii20-iii20
BACKGROUND: “Therapeutic Targeting of Glioblastoma” is a new pan-Canadian research team of the Terry Fox Research Institute and the Canadian Stem Cell Network funded to discover efficacious therapeutics for GBM. The team's goals are also to disco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a318fbf4aac84db806164dce772c7d8d
https://doi.org/10.1093/neuonc/nou206.72
https://doi.org/10.1093/neuonc/nou206.72
